Craven House Capital PLC
LSE:CRV
Intrinsic Value
Craven House Capital Plc seeks to acquire businesses in emerging and developed markets. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of CRV.
Fundamental Analysis
Balance Sheet Decomposition
Craven House Capital PLC
| Current Assets | 25k |
| Receivables | 25k |
| Non-Current Assets | 1.1m |
| Long-Term Investments | 1.1m |
| Current Liabilities | 114k |
| Accounts Payable | 114k |
| Non-Current Liabilities | 1.5m |
| Other Non-Current Liabilities | 1.5m |
Earnings Waterfall
Craven House Capital PLC
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-5.5m
USD
|
|
Operating Income
|
-5.5m
USD
|
|
Other Expenses
|
-102k
USD
|
|
Net Income
|
-5.6m
USD
|
Free Cash Flow Analysis
Craven House Capital PLC
What is Free Cash Flow?
CRV Profitability Score
Profitability Due Diligence
Craven House Capital PLC's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Craven House Capital PLC's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
CRV Solvency Score
Solvency Due Diligence
Craven House Capital PLC's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Craven House Capital PLC's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRV Price Targets Summary
Craven House Capital PLC
Shareholder Return
CRV Price
Craven House Capital PLC
| Average Annual Return | -56.69% |
| Standard Deviation of Annual Returns | 16.39% |
| Max Drawdown | -99% |
| Market Capitalization | 772.7k USD |
| Shares Outstanding | 3 863 580 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Craven House Capital Plc seeks to acquire businesses in emerging and developed markets. The firm is primarily engaged in investing in or acquiring a portfolio of companies, partnerships, joint ventures, businesses, or other assets participating in the e-commerce sector. Its investment portfolio comprises of Garimon Limited, Rosedog Limited, OneBas.com Limited, Honeydog Limited, and Bio Vitos Medical Limited. The firm is also involved in various activities, such as reverse takeover transactions, formation or identification of capital pool companies, going private transactions, advisory services (to assist companies with the identification, assessment and spin-in of products and/or subsidiaries and financial restructuring.
You don't have any saved screeners yet
